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Keratinocyte gene expression was surveyed more
comprehensively than before, by means of serial ana-
lysis of gene expression. A total of 25,694 tags
derived from expressed mRNA, were analyzed in a
model for normal differentiation and in a model
where cultured keratinocytes were stimulated for a
prolonged period of time with tumor necrosis fac-
tor-a, thus mimicking aberrant differentiation in the
context of cutaneous in¯ammation. Serial analysis of
gene expression revealed many transcripts derived
from unknown genes and a large number of genes
that are not known to be expressed in keratinocytes;
furthermore, these data provide quantitative infor-
mation about the relative abundance of transcripts,
allowing the identi®cation of differentially expressed
genes. A major part of the identi®ed transcripts
accounted for genes involved in energy metabolism
and protein synthesis. A large proportion of all tran-
scripts (6%) corresponded to genes associated with
terminal differentiation and barrier formation.
Another highly expressed functional group of genes
(2% of all transcripts) corresponded to proteins
involved in host protection such as antimicrobial
proteins and proteinase inhibitors. Three of these
genes were not known to be expressed in keratino-
cytes, and some were upregulated after prolonged
tumor necrosis factor-a exposure. Our data on
expressed genes in keratinocytes are consistent with
the known function of human epidermis, and pro-
vide a ®rst step to generate a transcriptome of
human keratinocytes. Key words: epidermis/cell culture/
differentiation/cytokines/genetics. J Invest Dermatol
116:12±22, 2001
T
he keratinocyte is the major cell type in mammalian
epidermis, which provides the organism with a
protective barrier against pathogens and chemical or
physical stimuli. A complex program of gene
expression underlies the tightly co-ordinated differ-
entiation of keratinocytes, and eventually leads to the unique
structure of the epidermis (Watt, 1989; Fuchs, 1993; Eckert et al,
1997). Proliferating, undifferentiated cells in the basal layer supply
the upper layers with new cells, which enter a state of terminal
differentiation. Ultimately, these cells die and form the outermost
corni®ed layer or stratum corneum in which the dead, ¯attened
cells or corneocytes form a covalently cross-linked protein network
embedded in lipids. In addition to the formation of the corni®ed
layer that provides a physical barrier, keratinocytes are also engaged
in innate and adaptive immunity. This is illustrated by the ability of
keratinocytes to present antigens (Otten et al, 1996), to express
various proteins involved in host protection (Pfundt et al, 1996;
Frohm et al, 1997; Harder et al, 1997; Wingens et al, 1998), and to
secrete cytokines and chemokines (Kupper, 1990). Furthermore,
keratinocytes have cytokine receptors and adhesion molecules on
their plasma membranes through which they interact with
in¯ammatory cells, and they can be regulated in both an autocrine
and paracrine fashion (Barker et al, 1991). Both the innate immune
response and the interaction with the immune system during
wound healing, skin infections, and in¯ammation, show that
keratinocytes serve as an important signaling interface between the
external environment and the organism.
There is considerable knowledge about gene expression pro®les
in human keratinocytes in vivo and in culture, especially on genes
encoding cytoskeletal and structural proteins (Eckert, 1989; Fuchs,
1995; Eckert et al, 1997). On the protein level Celis et al (1995)
have extensively analyzed gene expression in epidermis and
cultured keratinocytes, using two-dimensional polyacrylamide gel
electrophoresis (2D-PAGE) and microsequencing (see http://
biobase.dk/cgi-bin/celis/). Recently, a partial catalog of secreted
proteins in keratinocyte cultures was published by Katz and
Taichman (1999). No systematic studies on keratinocyte gene
expression at the mRNA level have been undertaken so far,
although a considerable amount of data is available from randomly
sequenced keratinocyte cDNA libraries (Konishi et al, 1994),
differential display polymerase chain reaction (PCR) (Frank and
Werner, 1996; Frank et al, 1997; Munz et al, 1997; Rivas et al,
1997; Rutberg et al, 1997; DiSepio et al, 1998) and cDNA ®lter
arrays (Trenkle et al, 1998).
In order to perform a systematic, comprehensive study of
keratinocyte gene expression at the mRNA level, we used serial
analysis of gene expression (SAGE; Velculescu et al, 1995). SAGE
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allows the rapid, quantitative, and simultaneous analysis of
thousands of genetic transcripts from a well-de®ned source, and
also provides information about their relative abundance. SAGE is
based on two principles: ®rst, a nucleotide sequence of 10 bp is
suf®cient to identify uniquely a transcript and second, by cloning
these 10 bp fragments or ``tags'' serially, along with a restriction
enzyme recognition sequence that serves as an anchor, a large
amount of transcripts can be identi®ed ef®ciently through
sequencing. To achieve this, mRNA is ®rst isolated and converted
to cDNA with biotinylated oligo-dT, and cDNA is then digested
with the restriction endonuclease NlaIII at the recognition
sequence CATG. This recognition sequence occurs randomly
every 256 bp, and serves as the anchor. The most 3¢ end fragments
of cDNA are isolated with streptavidin-coated magnetic beads,
then divided into two portions and ligated to two distinct linkers.
This is followed by digestion with a ``tagging'' endonuclease to
release the linker with a tag of approximately 10 bp. The two
portions are then combined to ligate, and the resulting ``ditag'' is
being ampli®ed with linker-speci®c primers. Ditags are then
liberated from linkers by NlaIII digestion, followed by ligation of
the ditags to form concatemers. These concatemers are cloned into
a suitable sequencing vector, allowing serial sequencing of ditags
(see Fig 1 for SAGE overview).
We have applied SAGE to analyze gene expression pro®les in a
keratinocyte culture model that we have previously described
(Pfundt et al, 1996; Van Ruissen et al, 1996). This model allows the
development of a differentiated phenotype in a submerged culture
system, as witnessed by the expression of involucrin, transglutami-
nase, and cytokeratins, CK1 and CK10. As it is known that
keratinocyte gene expression is altered under in¯ammatory
conditions (such as psoriasis or wound healing) that last for a
relatively long period of time, we investigated the indirect effect of
tumor necrosis factor (TNF-a) on cultured keratinocytes as a
model for in¯ammation-induced, long-term changes in epidermis.
Normally, TNF-a exerts a direct effect on its target cell in a matter
of hours. Ligation to one of its receptors, TNF receptor I or II, can
either lead to apoptosis within hours through a caspase-dependent
pathway, or induce a stress response through various pathways
Figure 1. Schematic overview of the SAGE
technique. A dashed line represents any possible
DNA sequence, and X and O represent any of
the four possible deoxynucleotides A, C, G, or T.
For explanation see introduction.
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leading to the activation of nuclear factor kb (NFkB) and,
subsequently, to the transcription of various genes (Schulze-Osthoff
et al, 1998; Wang et al, 1998; Wu et al, 1998). Stimulation of
cultured keratinocytes with TNF-a and other cytokines, however,
also sets off a cascade of events that can trigger secondary effects,
leading to long-term, aberrant differentiation as seen in in¯amma-
tory conditions of the skin. To investigate the changes in
keratinocyte gene expression due to these secondary effects, two
SAGE libraries from resting keratinocytes and keratinocytes after
long-term stimulation with TNF-a were constructed, and
subjected to further analysis as described in this study.
MATERIALS AND METHODS
Cells and cell culture Primary human epidermal keratinocytes were
obtained as previously described (Van Ruissen et al, 1996). Cells (16 3 106)
were grown to con¯uency in 75 cm2 culture ¯asks under keratinocyte
growth medium (KGM), consisting of KBM (0.15 mM Ca2+;
BioWhittaker, Verviers, Belgium) supplemented with ethanolamine
(0.1 mM; Sigma, St Louis, MO), phosphoethanolamine (0.1 mM, Sigma),
bovine pituitary extract (0.4% vol/vol; BioWhittaker, Verviers, Belgium)
epidermal growth factor (10 ng per ml; Sigma), insulin (5 mg per ml; Sigma),
hydrocortisone (0.5 mg per ml; Collaborative Research, Lexington, MA),
penicillin (100 U per ml; Life Technologies, Gaithersburg, MD), and
streptomycin (100 mg per ml; Life Technologies). Cells were switched to
KGM depleted of growth factors (bovine pituitary extract, epidermal
growth factor, hydrocortisone, and insulin) for 48 h before half of the cells
(8 3 106 cells) was switched to KGM depleted of growth factors for an
additional 48 h to induce normal differentiation, whereas the other half was
switched to KGM depleted of growth factors containing 25 ng per ml
TNF-a (R&D Systems, Minneapolis, MN). Non-adherent cells were
washed off with phosphate buffered saline, and RNA was isolated as
indicated below.
RNA isolation Total RNA was isolated from normal and stimulated
keratinocytes by lysing cells in RNase All [2.1 M guanidine thiocyanate
(Research Organics, Cleveland, OH), 8.5 mM N-laurylsarcosine (Sigma),
12.5 mM NaAc pH 5.2, 0.35% vol/vol b-mercaptoethanol (Merck GmbH,
Darmstadt, Germany) and 50% vol/vol Tris-saturated phenol pH 8.0
(Biosolve, Amsterdam, the Netherlands)], and total RNA was extracted by
adding 1/10 of a volume of chloroform and centrifugation at 12,000 3 g at
4°C for 15 min. The aqueous phase was recovered and total RNA was
precipitated by adding an equal volume of isopropanol, followed by an
incubation on ice for 45 min. RNA was pelleted by centrifugation at
12,000 3 g for 15 min, and the pellet was washed with 70% ethanol and
dried at room temperature. The pellet was then resuspended in 3.6 ml NSE
(50 mM NaAc, 0.2% sodium dodecyl sulfate, 2 mM ethylenediamine
tetraacetic acid) and 13.5 ml 100% ethanol was added. For quantitation,
100 ml of this suspension was used to pellet RNA, and the pellet was
resuspended in 1 ml H2O. Purity and concentration of total RNA were
determined spectrophotometrically. Subsequently, mRNA was isolated
using the QuickPrep Micro mRNA Puri®cation Kit (Pharmacia Biotech,
Uppsala, Sweden), according to the manufacturer's protocol.
SAGE Puri®ed mRNA was used to generate SAGE libraries from both
normal and stimulated keratinocytes, essentially as described previously
(Velculescu et al, 1995). The SAGE protocol and the SAGE Software
Package version 3.04 were kindly provided by Dr. K. Kinzler (Johns
Hopkins Oncology Center, Baltimore, MD). Isolated concatemers,
consisting of serially ligated tags, were ligated into pUC18 (Invitrogen,
San Diego, CA) and transformed in chemically competent MAX Ef®ciency
DH5a Escherichia coli Competent Cells (Life Technologies) by means of
heat-shock transformation, following the manufacturer's protocol. Colony
PCR (Ausubel, 1987) was performed on positive colonies with pUC18-
speci®c primers pUC18-F (5¢-AAGTTGGGTAACGCCAGG-3¢) and
pUC18-R (5¢-GGCTCGTATGTTGTGTGG-3¢) and PCR products
were analyzed by agarose gel electrophoresis. 1800 clones were selected
for DNA sequencing with the Big Dye Terminator Kit and the ± 21M13
sequencing primer (PE Applied Biosystems, Foster City, CA), according to
the manufacturer's recommendations. Sequencing reactions were run on an
ABI 310 Genetic Analyzer. Sequence data were analyzed with the SAGE
Software Package v3.04, and online with the SAGE analysis tools at the
website of the National Center for Biotechnology Information (NCBI),
Bethesda, MD (http://www.ncbi.nlm.nih.gov/SAGE/).
Reverse transcription±PCR Total RNA from which the SAGE
libraries were derived, was used for reverse transcription with Expand
Reverse Transcriptase (Boehringer Mannheim, Mannheim, Germany)
according to the manufacturer's protocol, followed by PCR following
standard protocols (Ausubel, 1987). Primers used for ampli®cation of the
corresponding gene transcripts were for radiation-inducible immediate-
early response gene 1 (IEX-1): 5¢-TGTCACTCTCGCAGCTGC-3¢ and
5¢-CTCTTCAGCCATCAGGATCTG-3¢; cytokeratin 1 (CK1): 5¢-
CTTGCTCTGGT ACAAGGACTCGGC-3¢ and 5¢-TTCCTTACAG
CACTCTACCA-3¢; and migration inhibitory factor-related protein 8
(MRP-8): 5¢-CGGGATCCATGTTGACCGAGCTGG-3¢ and 5¢-
CGGAATTCCTACTCTTTGTGGCTTTCT-3¢. Copy DNA were
cloned into the pGEM-T vector, according to the manufacturer's
recommendations (Promega, Madison, WI). Puri®ed plasmids were
sequenced in order to verify inserts.
Northern blot hybridization Northern blot analysis was essentially
carried out as described previously, and most cDNA clones have been
described elsewhere (Van Ruissen et al, 1996). The cDNA for cystatin M
was cloned as described previously (Sotiropoulou et al, 1997). Labelling
with [a-32P]deoxycytidine triphosphate was carried out with the
Oligolabeling Kit (Pharmacia Biotech) according to the manufacturer's
directions.
RESULTS
General results and statistics Cells were cultured under
conditions that allow differentiation in a submerged system as
previously described (Pfundt et al, 1996; Van Ruissen et al, 1996).
Messenger RNA was puri®ed from TNF-a-stimulated
keratinocytes and from an equivalent number of normally
differentiated cells, and analyzed using SAGE. A total number of
25,694 tags was generated, roughly half of which were from TNF-
a-stimulated cells and the other half from normal cells. A large
number of tags corresponding to genes known to be highly
expressed in epidermis were identi®ed, as well as many genes not
previously known to be expressed by keratinocytes. The expression
of several genes of these two categories was veri®ed by northern
blot hybridization. In all cases examined, the expression of genes
represented by tags in either SAGE library was con®rmed. A third
category of transcripts represents tags with matches to poorly
characterized expressed sequence tags (ESTs), or with no match in
the public mRNA databases. Approximately 6000 different tags
were expressed in each library, putatively corresponding to an equal
number of genes. Both libraries have a similar frequency
distribution. About 78% of unique genes are represented by only
one tag, whereas slightly more than 1% of unique genes identi®ed
in each library were represented by more than 20 tags; this is
independent of culture conditions (Table I). The combined data
set for the two libraries indicates that a total of 10,224 likely genes
has been identi®ed. Figure 2 shows that the number of genes
identi®ed is nearly proportional to the amount of tags sequenced,




Genes Tags Genes Tags
20 tagsb 72 (1.2%)c 3472 (27%) 80 (1.4%) 3820 (30%)
5±19 tags 271 (4.5%) 2331 (18%) 228 (3.9%) 2039 (16%)
2±4 tags 1018 (16.9%) 2509 (19%) 928 (16.0%) 2292 (18%)
1 tag 4653 (77.4%) 4653 (36%) 4578 (78.7%) 4578 (36%)
aCalculation of the frequency distribution of a given tag was based on a total
number of 12,965 sequenced tags from TNF-a stimulated keratinocytes, and
12,729 tags from resting keratinocytes. A total of 6014 unique genes was identi®ed
in the library of stimulated cells, and a total of 5814 genes was identi®ed in the
library of resting cells.
bTags per unique gene.
cPercentage of unique genes in frequency group.
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and extrapolation of the curve suggests that the theoretical number
of unique tags will be well over 12,000. Clearly, far more tags need
to be sequenced to obtain a complete and reliable coverage of
expressed genes (a ``transcriptome'') in these cells, as was previously
performed for Saccharomyces cerevisiae (Velculescu et al, 1997). In
Table II, 20 tags that are expressed at the highest levels in our
keratinocyte SAGE libraries, regardless of stimulation, are shown, as
well as their corresponding UniGene cluster. A list of tags found in
both libraries will be made available to the public at our Website
(http://dermatology.azn.nl/) in the near future. Statistical analysis
with the SAGE Software Package (v3.04) revealed that 90 genes
show a signi®cant difference (p < 0.05) in expression level. Forty-
seven genes were upregulated and 43 downregulated after TNF-a
stimulation. Of these 90 genes, 15 genes appeared to have no match
in UniGene, six matched solely with EST clusters, and 69 matched
with clusters of known genes in the UniGene database (Unigene
Build 108; see also http://www.ncbi.nlm.nih.gov/SAGE/ and
http://www.ncbi.nlm.gov/UniGene/), whereas some tags had
multiple matches with otherwise unrelated genes (Table III).
These data do not necessarily re¯ect the biologic relevance of
differential expression, as small differences between high scoring
tags obviously lead to high p-values. For instance galectin-7 shows
only a minor (less than 2-fold) decrease following TNF-a
stimulation, but this difference is statistically highly signi®cant
due the high expression levels of this gene (about 2% of the total).
Most genes that are expressed at high levels in keratinocytes, as
determined through SAGE, are those that are involved in cellular
energy metabolism and protein synthesis, which is in line with
previous reports (Velculescu et al, 1997; Chen et al, 1998; data not
shown). Keratinocytes, however, follow a unique differentiation
pathway that can be monitored by the expression of genes that are
associated with various stages of differentiation, and that also play an
important part in cytoskeleton assembly and epidermal barrier
function. Our data indicate that this class of genes is abundantly
expressed in our libraries (at least 6% of all transcripts) and is not
appreciably affected by TNF-a stimulation. Genes that are believed
to be involved in host defense and protection are also expressed at
substantial levels (about 2% of all transcripts). One of the intriguing
aspects of TNF-a is that it is able to either induce apoptosis or
promote survival through a pathway that involves the activation of
NF-kB (Wang et al, 1998). Several genes that are involved in either
pathway have been identi®ed in our libraries. A more detailed
overview of tags belonging to these functional classes of genes and
their regulation in aberrant, TNF-a-induced differentiation will be
presented below.
Genes coding for cytoskeletal and differentiation-related
proteins Genes that are associated with cytoskeleton assembly
and epidermal barrier function in keratinocytes are abundantly
expressed, irrespective of stimulation (Table IV). Cytokeratins
make up an important part of the cytoskeleton, and different
cytokeratins are expressed at various stages of differentiation. In
both SAGE libraries, CK5 and CK14 are among the most
abundantly expressed genes. CK14 showed the highest expression
of all keratins in the combined libraries, accounting for more than
1.5% of all transcripts. CK1 and CK10 are also found at high levels,
indicating that the model system allows a considerable degree of
differentiation. Expression levels of these cytokeratins did not
markedly differ between the two libraries (less than 1.5-fold),
Table II. The 20 tags with highest expression in the two combined SAGE libararies





TAAACCTGCT 518 Hs.99923 Lectin, galactoside-binding, soluble, 7 (galectin 7)
GATGTGCACG 406 Hs.117729 Keratin 14 (epidermolysis bullosa simplex, Dowling±Meara, Koebner)
CTTCCTTGCC 352 Hs.2785 Keratin 17
TGTGTTGAGA 286 Hs.181165 Eukaryotic translation elongation factor 1 a 1
Hs.251674 Eukaryotic translation elongation factor 1 a 1-like 14
CCCAAGCTAG 204 Hs.76067 Heat shock 27 kDa protein 1
CCCTTGAGGA 191 Hs.1076 Small proline-rich protein 1B (corni®n)
Hs.46320 Small proline-rich protein SPRK [human, odontogenic keratocysts, mRNA Partial, 317 nt]
GTGACCACGG 188 Hs.36451 Glutamate receptor, ionotropic, N-methyl D-aspartate 2C
Hs.244733 ESTs, highly similar to GLUTAMATE [Homo sapiens]
CTAAGACTTC 164 ± No match
GAAAACAAAG 163 Hs.99936 Keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris)
AAAGCACAAG 162 Hs.111758 Keratin 6B
CCCGTCCGGA 126 Hs.180842 Ribosomal protein L13
TTGGGGTTTC 122 Hs.62954 Ferritin, heavy polypeptide 1
TTGGTCCTCT 119 Hs.108124 Ribosomal protein L41
ACATTTCAAA 118 Hs.80828 Keratin 1 (epidermolytic hyperkeratosis)
GCCGTGTCCG 114 Hs.241507 Ribosomal protein S6
CCACAGGAGA 109 Hs.23579 ESTs
ATCCTTGCTG 104 Hs.2621 Cystatin A (ste®n A)
CCTGTAATCC 104 Multiple clusters Clusters matching multiple, unrelated genes
GTGGCCACGG 102 Hs. 112405 S100 calcium-binding protein A9 (calgranulin B)
TGGTGTTGAG 100 Hs. 75362 Ribosomal protein S18
aTotal number of tags from the combined data set of the two SAGE libraries, containing a total of 25,694 tags.
bDerived from UniGene Build 108; known genes are from GenBank 114 (December 1, 1999), ESTs are from dbEST through February 13, 2000.
Figure 2. The number of unique genes plotted against the number
of tags sequenced from the combined libraries. The number of
unique genes identi®ed is roughly proportional to the number of sequenced
tags. Sequence tags were generated and analyzed using the SAGE Software
Package v3.04.
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Table III. Differentially expressed tags in resting and TNF-a stimulated keratinocytes
Tag sequence Number of tags p-valueb UniGene clusterc Cluster name
per librarya
TNF-a Resting
TAAACCTGCT 194 324d 0.0000 Hs.99923 Lectin, galactoside-binding, soluble, 7 (galectin 7)
GTGACCACGG 148 40 0.0000 Hs.36451 Glutamate receptor, ionotropic, N-methyl D-aspartate 2C
Hs.244733 ESTs, highly similar to glutamate (H. sapiens)
GTAATCCTGC 30 3 0.0000 ± No match
TGGTGTTGAG 29 71 0.0000 Hs.75362 Ribosomal protein S18
AGAGGTGTAG 17 0 0.0000 Hs.135084 Cystatin C (amyloid angiopathy and cerebral hemorrhage)
GCCGTGTCCG 37 77 0.0001 Hs.241507 Ribosomal protein S6
TTCATACACC 7 29 0.0001 ± No match
TTGGTGAAGG 35 10 0.0002 Hs.75968 Thymosin, b 4, X chromosome
GCAACTTAGA 16 1 0.0002 Hs.54451 Laminin, gamma 2 [nicein (100 kDa), kalinin (105 kDa), BM600
(100 kDa), Herlitz junctional epidermolysis bullosa]
CAAGCATCCC 12 36 0.0003 ± No match
AAAGCACAAG 104 58 0.0003 Hs.111758 Keratin 6B
GTGGCCACGG 69 33 0.0003 Hs.112405 S100 calcium-binding protein A9 (calgranulin B)
CTCAACATCT 26 55 0.0006 Hs.73742 Ribosomal protein, large, P0
CCCATCGTCC 29 59 0.0007 ± No match
TACCTGCAGA 34 12 0.0011 Hs.100000 S100 calcium-binding protein A8 (calgranulin A)
CCGTCCAAGG 8 26 0.0013 Hs.80617 Ribosomal protein S16
CCCCCTGGAT 14 35 0.0016 Hs.183418 Cell division cycle 2-like 1 (PITSLRE proteins)
CTAAGACTTC 64 100 0.0019 ± No match
CCAGGGGAGA 9 0 0.0021 Hs.2867 Interferon-a-inducible protein 27
CGCGTCACTA 9 0 0.0021 Hs.135084 Cystatin C (amyloid angiopathy and cerebral hemorrhage)
CTTCCCTTGC 2 13 0.0032 ± No match
GACGACACGA 9 25 0.0038 Hs.153177 Ribosomal protein S28
CCCTTGAGGA 78 113 0.0043 Hs.1076 Small proline-rich protein 1B (corni®n)
Hs.46320 Small proline-rich protein SPRK (human, odontogenic keratocysts, mRNA
partial, 317 nt)
GAAAACAAAG 65 98 0.0043 Hs.99936 Keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris)
GCTCCCAGAC 8 0 0.0045 Hs.5097 Synaptogyrin 2
CCAGTGGCCC 10 26 0.0048 Hs.180920 Ribosomal protein S9
AAAAAAAAAA 5 18 0.0048 Multiple clusters Clusters matching multiple, unrelated genes
GCAACAACAC 20 6 0.0049 Hs.186571 TRF-proximal protein
CTCATAAGGA 28 11 0.0058 ± No match
TTGGGGTTTC 76 46 0.0058 Hs.62954 Ferritin, heavy polypeptide 1
CCCGTCCGGA 49 77 0.0060 Hs.180842 Ribosomal protein L13
TGATTTCACT 6 19 0.0065 Hs.181368 Myosin-binding protein C, cardiac
GCCTGCTGGG 24 9 0.0078 Hs.2706 Glutathione peroxidase 4 (phospholipid hydroperoxidase)
CGCTGGTTCC 9 23 0.0085 Hs.179943 Ribosomal protein L11
GTGGTACAGG 4 15 0.0086 Hs.23131 Kinesin family member C3
Hs.31731 ESTs, highly similar to putative peroxisomal antioxidant enzyme (H. sapiens)
ATCTTGTTAC 7 0 0.0086 Hs.118162 Fibronectin 1
ATCCTTGCTG 40 64 0.0089 Hs.2621 Cystatin A (ste®n A)
CCTGTAATCC 40 64 0.0089 Multiple clusters Clusters matching multiple genes
CGTGTTAATG 9 1 0.0107 Hs.2110 Zinc ®nger protein 9 (a cellular retroviral nucleic acid binding protein)
GAGATCCGCA 9 1 0.0107 Hs.247710 H. sapiens mRNA for preproprolactin-releasing peptide, complete cds
Hs.75348 Proteasome (prosome, macropain) activator subunit 1 (PA28 a)
CTGTCACCCT 33 54 0.0134 Hs.46320 Small proline-rich protein SPRK (human, odontogenic keratocysts, mRNA
Partial, 317 nt)
GAGGAGGGTG 27 12 0.0145 Hs.75318 Tubulin-a 1 (testis speci®c)
AAGAAGACTT 6 0 0.0145 Hs.7719 GABA(A) receptor-associated protein
CCACTGCATT 6 0 0.0145 Hs.199245 Inactivation escape 1
CCCTCAGCAC 6 0 0.0145 Hs.87268 Annexin A8
CTCATAAGGG 6 0 0.0145 Hs.29835 Wingless-type MMTV integration site family, member 2B
GGTTGAGTGT 6 0 0.0145 Hs.20529 ESTs
CTGTTGGTGA 15 30 0.0149 Hs.3463 Ribosomal protein S23
TAAGCCTGCT 0 6 0.0150 ± No match
TGGTGTTAAG 0 6 0.0150 Hs.75362 Ribosomal protein S18
AGCCCTACAA 6 17 0.0164 ± No match
AGCAGATCAG 31 15 0.0165 Hs.119301 S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light poly-
peptide (p11)
CTTCTTGCCT 14 4 0.0165 Hs. 128095 ESTs, moderately similar to glutamate receptor, ionotropic kainate 5 precur-
sor (H. sapiens)
Hs.75792 Hemoglobin, a 1
GATGTGCACG 227 179 0.0178 Hs.117729 Keratin 14 (epidermolysis bullosa simplex, Dowling±Meara, Koebner)
GCCCGTGTCC 1 8 0.0178 Hs.241507 Ribosomal protein S6
ACGCAGGGAG 23 10 0.0200 Hs.180532 Heat shock 90 kDa protein 1, a
CCCATCCGAA 29 47 0.0213 Hs. 91379 Ribosomal protein L26
ATCGTGGAGG 10 2 0.0223 Hs.727 Inhibin, b A (activin A, activin AB a polypeptide)
GGTGAGACAC 8 1 0.0227 Hs.164280 Adenine nucleotide translocator 3 (liver)
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although the difference was signi®cant for CK10 and CK14. CK6b,
CK16, and CK17 are in vivo usually seen following stress and during
hyperproliferation (Leigh et al, 1995), but are invariably found in
cultured keratinocytes. In both libraries CK17 was highly expressed
at equal levels, whereas CK6b was signi®cantly upregulated after
TNF-a stimulation. CK2e, a cytokeratin found in the stratum
Tag sequence Number of tags p-valueb UniGene clusterc Cluster name
per librarya
TNF-a Resting
TAAAATGTAT 8 1 0.0227 Hs.161566 ESTs
Hs.194104 ESTs, weakly similar to intrinsic factor-B12 receptor precursor (H. sapiens)
GGCAAGAAGA 13 26 0.0235 Hs.111611 Ribosomal protein L27
CCTCGGAAAA 6 16 0.0249 Hs.2017 Ribosomal protein L38
TGTGCTAAAT 9 20 0.0249 Hs.250895 Ribosomal protein L34
AGGGCTTCCA 26 13 0.0289 Hs.29797 Ribosomal protein L10
TTTGTAGAGG 16 6 0.0304 Hs.32426 ESTs
CCCCTTGAGG 1 7 0.0305 ± No match
AAGGGCGCGG 0 5 0.0316 Hs.1378 Annexin A3
ACAGTGATGA 0 5 0.0316 ± No match
ACCGCCTGTG 0 5 0.0316 Hs.240443 ESTs, weakly similar to HNK-1 sulfotransferase (H. sapiens)
ATGTAAAATC 0 5 0.0316 Hs.111758 Keratin 6B
CTCATCTGCT 0 5 0.0316 Hs.82109 Syndecan 1
GATGCGCACG 0 5 0.0316 ± No match
GTGTAATAAG 0 5 0.0316 Hs.75598 Heterogeneous nuclear ribonucleoprotein A2/B1
AACGAGGAAT 5 0 0.0332 ± No match
AAGAGTTTTG 5 0 0.0332 Hs.75313 Aldo-keto reductase family 1, member B1 (aldose reductase)
AAGCTGTGTC 5 0 0.0332 Hs.108332 Ubiquitin-conjugating enzyme E2D 2 (homologous to yeast UBC4/5)
AATGCTTTGT 5 0 0.0332 Hs.248323 Tubulin-a, brain speci®c
CCTTCCCATA 5 0 0.0332 ± No match
CGCTGTGGGG 5 0 0.0332 Hs.7486 Protein expressed in thyroid
GAAGCAGGAC 5 0 0.0332 Hs.180370 Co®lin 1 (nonmuscle)
GACTTCACTT 5 0 0.0332 Hs.77356 Transferrin receptor (p90, CD71)
GATGTGCACT 5 0 0.0332 ± No match
GCTGGCTGGC 5 0 0.0332 Hs.108809 Chaperonin containing TCP1, subunit 7 (eta)
TAGGGCAATC 5 0 0.0332 Hs.180139 SMT3 (suppressor of mif two 3, yeast) homolog 2
TGAGTCTGGC 5 0 0.0332 Hs.4055 Core promoter element binding protein
CACAAACGGT 29 45 0.0341 Hs.195453 Ribosomal protein S27 (metallopanstimulin 1)
AGGGTGGTGA 7 1 0.0368 Hs.44036 ESTs
TGACTGGCAG 7 1 0.0368 Hs.119663 CD59 antigen p18-20 (antigen identi®ed by monoclonal antibodies 16.3A5,
EJ16, EJ30, EL32 and G344)
TGTTTATCCT 3 10 0.0409 Hs.78888 Diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A
binding protein)
CTCATAGCAG 16 28 0.0417 Hs.119252 Tumor protein, translationally controlled 1
aSAGE library of TNF-a-stimulated keratinocytes contains a total of 12,965 tags, whereas the library of resting keratinocytes contains 12,729 tags.
bAll signi®cant differences in expression levels with p <0.05 are sorted according to signi®cance level. Tags were analyzed using the SAGE Software Package 3.04, and p-
values were determined by performing Monte Carlo simulations, given the null hypothesis that the level, kind and distribution of tags is the same for both libraries.
cDerived from UniGene Build 108; known genes are from GenBank 114 (December 1, 1999), ESTs are from dbEST through February 13, 2000.
dBold numbers indicate upregulation in respective library.
Table III. Continued.
Table IV. Tags corresponding with transcripts of genes involved in epidermal barrier function and keratinization
Tag sequence Frequency (%)a Fold up-/down- Gene
regulation
+ TNF ± TNF + TNFb
GATGTGCACG 1.75 1.41 1.2 Cytokeratin 14c
CTTCCTTGCC 1.30 1.45 ±1.1 Cytokeratin 17
AAAGCACAAG 0.80 0.46 1.7 Cytokeratin 6c
CCCTTGAGGA 0.60 0.89 ±1.5 Small proline-rich protein Ic
GAAAACAAAG 0.50 0.77 ±1.5 Cytokeratin 10c
ACATTTCAAA 0.43 0.49 ±1.1 Cytokeratin 1
GCCCCTGCTG 0.39 0.36 1.1 Cytokeratin 5
GGCTTCTAAC 0.13 0.12 1.1 Small proline rich protein II
CAGCTGTCCC 0.10 0.09 1.1 Cytokeratin 16
TCTCTTTAAT 0.05 0.09 ±1.8 Involucrin
CTGCTCAATG 0.04 0.03 1.3 Transglutaminase 1
TCTTAACCTA 0.008 0 NDd Loricrin
aFrequency as percentage of the total number of tags in a given library.
bBased on relative frequencies of a particular sequence tag.
cSigni®cantly upregulated or downregulated, p < 0.05.
dND, not determined: no meaningful ratio due to low frequency.
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granulosum of normal skin (Steinert and Marekov, 1995) was not
detected in either library. Small proline-rich proteins I and II (also
referred to as corni®ns) make up an important structural part of the
corni®ed layer and were found at high levels in both libraries.
Transglutaminase 1, an enzyme involved in protein cross-linking
during assembly of the corni®ed layer, and involucrin were found
in both libraries at moderate levels. Loricrin and ®laggrin, two
major components of the stratum corneum (Steven and Steinert,
1994; Candi et al, 1995), were not detected in the library of
normally differentiated cells, although one tag for loricrin was
found in the library from TNF-a-stimulated cells. The absence of
CK2e, ®laggrin, and a substantial number of tags for loricrin is
consistent with the absence of a morphologically recognizable
stratum granulosum in submerged cultures.
Genes involved in host protection In addition to the
formation of a physical skin barrier, keratinocytes are involved in
the protection of the host against microbial attack, and in the
protection of the tissue against self proteinases derived from
in¯ammatory cells. The presence of several antimicrobial proteins
like skin-derived anti-leukoproteinase (SKALP/ela®n), secretory
leukoprotease inhibitor (SLPI), b-defensin 2, and cystatin A has
been described in epidermis. In addition, SKALP/ela®n, SLPI, and
cystatin A are also proteinase inhibitors. Remarkably, this class of
genes was highly expressed in our libraries (TableV). High levels
of SLPI, SKALP/ela®n, MRP-8 and MRP-14 (also referred to as
calgranulins) and various cystatins were found (almost 2% of the
total number of tags). The expression of these cystatins, except
cystatin A, has not been reported previously for adult human
keratinocytes. The recently discovered cystatin M (Sotiropoulou
et al, 1997) and cystatins B and C are also expressed in
keratinocytes. For cystatin C two tags were found that could be
assigned to the cystatin C UniGene cluster (Hs.135084). One tag
that corresponds to the known cDNA sequence is not differentially
expressed, whereas another tag assigned to the cystatin C cluster on
the basis of assembled ESTs (tag-to-gene analysis, http://www.
ncbi.nlm.nih.gov/SAGE/SAGEtag.cgi) is highly upregulated after
TNF-a stimulation (see Table III). Other genes that play a part in
host protection, such as SKALP and SLPI, are expressed in both
libraries at high levels. These proteins are inhibitors of leukocyte-
derived proteinases (Molhuizen et al, 1993; Pfundt et al, 1996;
Sotiropoulou et al, 1997; Zeeuwen et al, 1997), and SLPI has both
anti-microbial and anti-viral properties (Wingens et al, 1998, and
references therein). SKALP/ela®n is a member of the recently
described trappin gene family (Schalkwijk et al, 1999) and is involved
in the protection against microbial infection (Simpson et al, 1999).
MRPs are calcium-binding proteins, and it has been demonstrated
that MRP-8 and MRP-14 can form a heterodimer and have anti-
microbial activity in vitro (Brandtzaeg et al, 1995; Santhanagopalan
et al, 1995; Loomans et al, 1998). Both proteins are signi®cantly
upregulated after TNF-a stimulation. Ubiquicidin, a new anti-
microbial protein recently described in murine macrophages
(Hiemstra et al, 1999), is abundantly expressed in cultured
keratinocytes, irrespective of stimulation. It exists as a post-
translational modi®cation of the fau gene product and has not been
described previously in human epithelial cells. A tag corresponding to
the human fau gene was found at signi®cant levels in both SAGE
libraries. Members of the serprocidin family (Nathan and Gabay,
1992), which are abundantly expressed in human neutrophils, were
not found with the notable exception of the proteinase/antimicrobial
cathepsin G, of which two tags were found in the library of TNF-a
stimulated keratinocytes. b-defensins 1 and 2 were found at low levels
after TNF-a stimulation, whereas b-defensin 1 was only present in
normally differentiated keratinocytes.
Genes involved in apoptosis and survival Exposure of target
cells to TNF-a can either lead to apoptosis or the induction of gene
expression leading to cell survival. TNF-a can induce apoptosis by
triggering a proteolytic cascade through its receptor TNF-R1,
eventually leading to DNA fragmentation and cell death. In our
hands TNF-a did not induce apoptosis in keratinocytes when
applied at concentrations up to 25 ng per ml. Two inhibitors of
TNF-mediated apoptosis were, however, detected: IEX-1 and
cellular inhibitor of apoptosis protein 2 (TableVI). IEX-1 was
originally identi®ed in keratinocytes, and its expression is mediated
through NFkB (Wu et al, 1998). IEX-1 is only represented by one
tag after TNF-a stimulation. Clearly, such small differences do not
allow conclusions on differential expression; however, when IEX-1
expression was checked by northern blot analysis, a clear signal was
obtained showing a strong upregulation following TNF-a
stimulation (data not shown). Of special interest is the presence
of TNF-related apoptosis inducing ligand (TRAIL) in both libraries
as well as herpes virus entry mediator ligand (HVEM-L), as their
gene products can induce apoptosis in various transformed and
tumor cell lines (Wiley et al, 1995; Pitti et al, 1996; Mauri et al,
1998; Zhai et al, 1998), but can also induce the NFkB pathway in
various cell types (Chaudhary et al, 1997; Harrop et al, 1998) albeit
to a lesser extent than TNF-a. One of the receptors for TRAIL,
TRAIL receptor 2 (also known as KILLER and death receptor 5),
was also identi®ed in both libraries (Table VI).
Apoptosis can also be the result of a balance between the
expression of pro-apoptotic and anti-apoptotic genes of the Bcl
family, which appeared to be expressed in our libraries at
surprisingly high levels (TableVI). It has been shown that Bak, a
pro-apoptotic gene, is expressed in both normal and in¯amed skin
(Tomkova et al, 1997), most prominently in the granular layer, just
Table V. Tags corresponding with transcripts of genes involved in host protection and their upregulation and
downregulation after TNF-a stimulation
Tag sequence Frequency (%) Fold up-/down- Gene
regulation
+ TNF ± TNF + TNF
GTGGCCACGG 0.53 0.26 2.0 MRP-14a
TGTGGGAAAT 0.42 0.34 1.2 SLPI
ATCCTTGCTG 0.31 0.50 ±1.6 Cystatin Aa
TACCTGCAGA 0.26 0.09 2.9 MRP-8a
TTGAATCCCC 0.17 0.19 ±1.1 SKALP
ATGAGCTGAC 0.13 0.13 1 Cystatin B
GTTCCCTGGC 0.10 0.09 1.1 Ubiquicidin
GTGGAGGGCA 0.09 0.04 2.3 Cystatin M
TGCCTGCACC 0.07 0.07 1 Cystatin C
CACTCCAGCC 0.015 0 NDb Cathepsin G
AGAACTTCCT 0.008 0.015 ±2 b-Defensin 1
TAAACCAAAT 0.008 0 NDb b-Defensin 2
aTranscripts with a signi®cant difference in expression level after TNF-a stimulation, p < 0.05.
bND, not determined: no meaningful ratio due to low frequency.
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before the ®nal steps that lead to the formation of the corni®ed
layer. Bak is also expressed in our culture model, irrespective of
stimulation. The pro-apoptotic proteins Bad and Bax are also
expressed, albeit at lower levels. One pro-apoptotic protein, Nbk/
Bik, has never been described in keratinocytes; its tag occurs once
in the library from normally differentiated cells. Bag-1 is a potent
inhibitor of apoptosis and Fas-induced cell death (Takayama et al,
1995), and its expression has never been described in keratinocytes
either.
Veri®cation of SAGE data by northern blot
analysis Although the high expression levels of several genes in
the SAGE libraries (already known from epidermis and cultured
keratinocytes) suggested that the data obtained were valid at least
for the high scoring tags, we wanted to verify some of the data by
an independent method. To this end we selected various tags
corresponding with genes for which probes were available in our
lab, or for which probes could be generated by means of reverse
transcription±PCR. Primers for reverse transcription±PCR are
based on mRNA sequences as deposited in GenBank. Reverse
transcription±PCR products were cloned into the pGEM-T vector
and PCR products were checked by sequence analysis. For
northern blotting, RNA was used from which the two libraries
are derived, and equal loading was veri®ed by the staining of
ribosomal RNA with methylene blue before northern blot
hybridization (Fig 3B). As seen in Fig 3(A), CK1 and CK16 are
expressed in resting and stimulated cells at similar levels, correlating
well with SAGE data. MRP-8 is upregulated almost 3-fold
according to the SAGE data (p < 0.01), which was con®rmed by
northern blot hybridization. Human acidic ribosomal protein P0, a
housekeeping gene, appears to be downregulated more than 2-fold
after TNF-a stimulation (p < 0.001), which is also con®rmed by
northern blot hybridization. IEX-1, a gene previously shown to be
upregulated by TNF-a (Kondratyev et al, 1996), was only
represented by one tag after TNF-a stimulation. Northern blot
hybridization, however, revealed that IEX-1 is indeed markedly
upregulated (data not shown).
DISCUSSION
We have applied SAGE technology in order to make a
comprehensive study of keratinocyte gene expression in vitro.
The major goal was to obtain insight into the repertoire of
expressed genes in these cells, and a second goal was to examine the
long-term, secondary effect of a pro-in¯ammatory cytokine, as it is
known that epidermal differentiation is altered in the context of
in¯ammation. SAGE allows the generation of a catalog of
thousands of expressed genes, without any prior knowledge of
the cell's repertoire, and has the additional advantage of discovery
of new genes. When large numbers of tags are sequenced to obtain
a several-fold coverage of the expressed genes, as was performed in
yeast, a so-called transcriptome is obtained (Velculescu et al, 1997).
In our study a total of 25,000 tags were analyzed in the combined
libraries that allows the identi®cation of more than 10,000
expressed genes in keratinocytes using a well-de®ned culture
system (Fig 2); however, a limitation of the approach is that only a
small part of the genes are expressed at suf®cient levels to allow a
statistically reliable comparison between the normal and aberrantly
differentiated cells. This problem can be overcome by simply
sequencing more tags, i.e., by increasing the sample size.
Nevertheless, a wealth of data is generated in our analysis because:
(i) it is has uncovered many genes not previously known to be
expressed by keratinocytes; (ii) differential gene expression has been
demonstrated for 90 genes after prolonged TNF-a stimulation; and
(iii) several tags have been identi®ed that have no match in the
public databases, and thus potentially represent new genes.
Figure 3. Veri®cation of SAGE data by northern blot hybridization.
Ten micrograms of total RNA from which either library was derived was
loaded on a 1% agarose gel, blotted to nitrocellulose membrane and
hybridized with probes for the genes indicated (A). Equal loading was
veri®ed by methylene blue staining of 28S and 18S rRNA (B). CK,
cytokeratin; hARP, human acidic ribosomal protein; MRP, migration
inhibitory factor-related protein; ND, not determined: no meaningful ratio
obtained due to low frequency; NS: not signi®cant according to SAGE
data.
TableVI. Tags corresponding with transcripts of genes
associated with apoptosis and survivala
Tag sequence Number of tags Gene
+ TNF ± TNF
CTCCTCACCT 10 10 Bak
GCAAAACCCC 6 2 HVEM-L
CCACTACACT 3 2 TRAIL
AAAGTCTAGA 1 0 Bcl-1
GAGGCGCTGG 1 0 Bad
TTAATTGGGA 1 1 Bag-1
ACAATCATCC 1 0 Bcl-2
GGCATTTTTC 1 3 Bax
ATGCCTTTTT 0 1 Nbk/Bik
ACCGGTACTG 1 0 TRAIL-R2
ACCAAATTAA 0 1 TRAIL-R2 (variant)
ACCATCCTGC 1 0 IEX-1
TTCTAGTCTG 0 1 hIAP-2
aHVEM-L, herpes virus entry mediator ligand; TRAIL-R2, TRAIL receptor 2.
Difference between expression levels of genes associated with apoptosis and
survival was statistically not signi®cant (p < 0.05).
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We have sought to analyze gene expression in keratinocytes in a
submerged culture system, and we compared gene expression of
normally differentiated keratinocytes with those stimulated with
TNF-a, a potent pro-in¯ammatory cytokine which is likely to play
an important part in various pathologic conditions of the skin. It
should be noted that TNF-a is able to induce a response in the
target cell within minutes, leading to rapid changes at the
transcriptional level; however, in this study we have chosen to
analyze the indirect effects of TNF-a stimulation after 48 h of
addition to cultured keratinocytes, as a model system to examine
the long-term effects of an in¯ammatory stimulus on keratinocyte
gene expression. The results indicate that at least 10,000 genes are
expressed by keratinocytes, irrespective of stimulation, most of
which are involved in protein synthesis and metabolism (data not
shown). Based on the results of 2D-PAGE and large-scale protein
sequencing (Celis et al, 1995) it has been established that in
keratinocytes 2315 gene products can be identi®ed at the protein
level. Allowing for redundancy and isoforms, over 100 unique
genes could be attributed to these 2315 sequenced proteins
according to UniGene cluster analysis, thus identifying more than
100 unique genes that are expressed at the protein level (http://
biobase.dk/cgi-bin/celis/). This number is far less than the number
of expressed genes in our two SAGE libraries. Gygi et al (1999),
however, have shown that, although many genes are found to be
differentially expressed through SAGE and northern blot hybridi-
zation in yeast during the cell cycle (Velculescu et al, 1997),
expression levels of genes at the protein level can greatly differ from
the SAGE data. This ®nding implies that one should be cautious in
the interpretation of data concerning mRNA levels, and that the
catalog generated through SAGE should only be considered a
rough indication of which genes are active, and is by no means
conclusive with regard to their presence at the protein level.
Furthermore, only 90 genes or approximately 1% of all genes
identi®ed show a signi®cant upregulation or downregulation after
TNF-a stimulation, indicating that relatively few genes are
involved in the profound phenotypic and biochemical changes
that are usually seen after cytokine-induced aberrant differentiation.
The relative amount of differentially expressed genes appears to be
in line with other reports in which SAGE was used as a means to
study gene expression: in the comparison of normal colon and
cancer cells, more than 500 genes of 49,000 different genes
identi®ed, or about 1%, appeared to be differentially expressed
(Zhang et al, 1997). In the case of p53-induced gene expression,
only 34 of 7202 genes identi®ed, or less than 0.5%, appear to be
markedly, i.e., more than 10-fold, upregulated or downregulated
(Polyak et al, 1997). Interestingly, many of the differentially
expressed tags are present in ESTs that have been assigned to
UniGene clusters of known genes (Table III). It is clear from the
UniGene clusters that various different tags can represent a single
gene, as is the case for tags AGAGGTGTAG and CGCGTCACTA
of which the corresponding ESTs have been assigned to the
UniGene cluster of cystatin C, as has the tag TGCCTGCACC,
which also corresponds with the original mRNA in GenBank
(accession number X05607). This may be the result of alternative
polyadenylation, alternative splicing, or polymorphisms in the
mRNA from which these tags are derived. One should also bear in
mind that ESTs are in general poorly characterized, and that tags
can incorrectly be assigned to a particular UniGene cluster as a
result of sequencing artifacts. It should be noted that UniGene is
constantly evolving, and that the assignment of tags to genes may
change over time, as more data become available from the Human
Genome Project and the characterization of ESTs. A minority of
the identi®ed tags correspond with several different genes. Two
prominent examples are the tags AAAAAAAAAA and
CCTGTAATCC, which match with multiple UniGene clusters.
This may be due to the presence of conserved sequences and
common repeats in the 3¢ untranslated regions of various mRNA.
Independent assays, e.g., northern blotting, are then needed to
ascertain from which gene, or combination of genes, the observed
tags are derived. Positive identi®cation of the corresponding genes,
and their biologic signi®cance in aberrant TNF-a-induced
differentiation awaits further investigation.
Our results indicate that in this submerged keratinocyte culture
model, genes involved in epidermal barrier function are expressed,
predominantly associated with the early differentiation of kerati-
nocytes; their expression is also not modi®ed to a great extent by
TNF-a stimulation. As the cultures consist of a monolayer of basal
cells with scattered differentiated cells on top (Van Ruissen et al,
1996), the cytokeratins typical for basal cells (CK5 and CK14) are
highly expressed, accounting for about 2% of all transcripts. CK14
was expressed at signi®cantly higher levels (p < 0.05, see also
Table IV) after TNF-a stimulation, but it remains to be
determined whether its slight (less than 2-fold) upregulation is
biologically signi®cant, as it is expressed in both libraries at very
high levels. Because there are two cell populations within the
cultures (basal cells and differentiated cells), the observed difference
could also re¯ect the relative cell numbers of each population. As
the expression levels of CK1 and CK10 are somewhat lower in the
TNF-a-stimulated cultures, it is very well possible that TNF-a
stimulation has caused a minor shift in the two populations. The
observation that CK1 and CK10 are highly expressed (about 1% of
all tags) indicates that a considerable degree of differentiation has
occurred in these cultures. The epidermal expression of CK6b,
CK16, and CK17 in vivo is usually restricted to conditions of
hyperproliferation, abnormal epidermal differentiation, and wound
healing, whereas these genes are always expressed in cultured
keratinocytes. CK6b, CK16, and CK17 are believed to be involved
in keratinocyte migration at the wound edge, where they are
involved in the reshuf¯ing of the intermediate keratin ®laments
(Paladini et al, 1996). Only CK6b was signi®cantly upregulated
after TNF-a stimulation (nearly 2-fold, p < 0.001). Other
differentiation-related genes that were found include the small
proline-rich proteins I and II, involucrin, and transglutaminase.
Genes that are expressed during the late stages of differentiation are
either absent, as is the case for ®laggrin and CK2e, or hardly
present, such as loricrin. From these data we can conclude that the
culture model used here has some characteristics of normal
epidermis, but is still very similar to that of psoriatic epidermis,
which is known to be positive for CK6, CK16, and CK17, and
where a morphologically recognizable granular layer, and expres-
sion of ®laggrin and loricrin is markedly reduced (Bernard et al,
1988; Ishida-Yamamoto et al, 1996).
Apart from housekeeping genes and differentiation-related
genes, a third functional group of proteins is abundantly expressed.
This group involved in host protection, comprises proteinase
inhibitors and anti-microbial proteins. In many cases these
properties are found within the same molecule as in the dual
function proteins SLPI (Wiedow et al, 1998; Wingens et al, 1998),
some of the cystatins (Bjorck, 1990; Takahashi et al, 1994;
Blankenvoorde et al, 1998), and also SKALP/ela®n (Schalkwijk
et al, 1999; Simpson et al, 1999). It is clear that keratinocytes invest
large efforts in expression of these proteins (almost 2% of all tags),
which is consistent with the function of the epidermis. Previous
studies have indicated that the expression of these proteins is not
restricted to cultured keratinocytes, but is also found in normal and
in¯amed human epidermis (Takahashi et al, 1992; Schalkwijk et al,
1993; Harder et al, 1997; Wingens et al, 1998; Schroder and
Harder, 1999). As some of these molecules are known to be
upregulated during in¯ammation in vivo, we expected an effect of
TNF-a stimulation. This was indeed found to be the case for
MRP-8 and MRP-14, a ®nding that was further con®rmed on
northern blots. The fact that some of these molecules are already
expressed at high levels, whereas in normal skin their expression is
limited, further underlines that the nonstimulated culture from
which the SAGE library was derived is in some respects more
similar to psoriatic epidermis, as witnessed by the expression of
CK6, CK16, CK17, SLPI, and SKALP/ela®n. The model system
using growth factor depleted medium to induce normal differ-
entiation is sensitive to other factors such as con¯uency of the
cultures. We have recently found that by carefully controlling these
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factors the expression of psoriasis-associated genes is suppressed.
This makes the model system more sensitive to proin¯ammatory
cytokines such as TNF-a, and we found that, e.g., SKALP
expression is under (indirect) control of TNF-a provided that the
initial SKALP expression levels are low (Pfundt et al, 2000). This
suggests that, although we ®nd signi®cant differences between the
two libraries, our study might underestimate the quantitative and
qualitative effects of TNF-a on keratinocyte gene expression.
At this moment SAGE appears to be one of the most powerful
methods for expression pro®ling, because in addition to yielding
quantitative expression data it allows new genes to be discovered.
Obviously, when the entire set of human genes is known,
microarrays covering the entire genome will be the ®rst choice
for expression pro®ling studies. In conclusion, we think that these
data provide basic, partial information on gene expression in
keratinocytes and long-term differences induced by TNF-a
stimulation. This analysis could be a ®rst step towards a
transcriptome of primary human cells, which could provide a
wealth of information for future research in keratinocyte biology.
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